Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia

The Mouse Brain in Stereotaxic Coordinates

Paxinos, G. (2001) · Cited by 12,859

mouse brain in stereotaxic coordinates

Franklin, K. B. J., & Paxinos, G. (1997) · Cited by 3,258

Recent advances in the phencyclidine model of schizophrenia

(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904

Heteromeric NMDA receptors: molecular and functional distinction of subtypes

Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., Burnashev, N., Sakmann, B., & Seeburg, P. H. (1992) · Science · doi:10.1126/science.256.5060.1217 · Cited by 2,541

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476

Antipsychotic drug doses and neuroleptic/dopamine receptors

SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622

Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies

Crawley, J. N., Belknap, J. K., Collins, A. C., Crabbe, J. C., Frankel, W. N., Henderson, N. D., HITZEMANN, R. J., Maxson, S. C., Miner, L. L., Silva, A. J., et al. (1997) · Psychopharmacology · doi:10.1007/s002130050327 · Cited by 1,372

Molecular diversity of the NMDA receptor channel

Kutsuwada, T., Kashiwabuchi, N., Mori, H., Sakimura, K., Kushiya, E., Araki, K., Meguro, H., Hisashi, M., Kumanishi, T., Arakawa, M., et al. (1992) · Nature · doi:10.1038/358036a0 · Cited by 1,352

HPRT-deficient (Lesch–Nyhan) mouse embryos derived from germline colonization by cultured cells

Hooper, M., Hardy, K., Handyside, A. H., Hunter, S., & Monk, M. (1987) · Nature · doi:10.1038/326292a0 · Cited by 1,218

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

Carlsson, M. L., & Carlsson, A. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90108-m · Cited by 1,086

Transcending Psychosis

Yum, S. Y., Hwang, M. Y., Nasrallah, H. A., & Opler, L. A. (2016) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2016.01.007 · Cited by 6

Effect of adolescent androgen manipulation on psychosis-like behaviour in adulthood in BDNF heterozygous and control mice

Du, X., McCarthny, C. R., Notaras, M. J., van den Buuse, M., & Hill, R. (2019) · Hormones and Behavior · doi:10.1016/j.yhbeh.2019.03.005 · Cited by 6

Central Actions of 3α,5α-THP Involving NMDA and GABAA Receptors Regulate Affective and Sexual Behavior of Female Rats

Frye, C. A., Qrareya, A. N., Llaneza, D. C., & Paris, J. J. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.00011 · Cited by 6

Modulation on Glutamic Pathway of Frontal-Striatum-Thalamus by rs11146020 and rs3813296 Gene Polymorphism in First-Episode Negative Schizophrenia

Cai, S., Lv, Y., Huang, K., Zhang, W., Wang, Q., Huang, L., & Wang, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00351 · Cited by 6

Solute Carrier Family 1 (SLC1A1) Contributes to Susceptibility and Psychopathology Symptoms of Schizophrenia in the Han Chinese Population

Li, W., Su, X., Chen, T., Li, Z., Yang, Y., Zhang, L., Liu, Q., Shao, M., Zhang, Y., Ding, M., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.559210 · Cited by 6

Activation of A2Badenosine receptor protects against demyelination in a mouse model of schizophrenia

Ma, Q., Wang, D., Li, Y., Yang, H., Li, Y., Wang, J., Li, J., Sun, J., & Liu, J. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11323 · Cited by 6

Role of pharmacogenomics in drug development

Hakonarson, H. H., & Stefánsson, K. (2004) · Drug Development Research · doi:10.1002/ddr.10367 · Cited by 6

Response to Comment on "Diverse Psychotomimetics Act Through a Common Signaling Pathway"

Svenningsson, P., Nomikos, G. G., & Greengard, P. (2004) · Science · doi:10.1126/science.1097564 · Cited by 6

Theory of mind in schizophrenia: Damaged module or deficit in cognitive coordination?

Leiser, D., & Bonshtein, U. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03350022 · Cited by 6

Combined effect of polymorphic sites in the DTNBP1 and GRIN1 genes on schizophrenia

Galehdari, H., Ajam, T., Pooryasin, A., Mohammad, F. A., & Reza, K. S. (2010) · Medical Journal of the Islamic Republic of Iran · Cited by 6

NMDA Receptors

Petralia, R. S., & Wenthold, R. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-055-3_2 · Cited by 7

Cognitive coordination and its neurobiological bases: A new continent to explore

Silverstein, S. M., & Phillips, W. A. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x0349002x · Cited by 6

Context rules

Bressler, S. L. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03250020 · Cited by 6

The effects of psychotomimetics and psychomotor stimulants on two schedules promoting response switching in the rat

Evenden, J. L. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1184-1 · Cited by 6

Restoring striatal WAVE-1 improves maze exploration performance of GluN1 knockdown mice

Chen, Y., Milenkovic, M., Horsfall, W., Salahpour, A., Soderling, S. H., & Ramsey, A. J. (2018) · PLOS ONE · doi:10.1371/journal.pone.0199341 · Cited by 5

Electrophysiological Deficits in Schizophrenia: Models and Mechanisms

von Reyn, C. R., Michael, E., Freedman, R., Valerie, M., Michael, J., Chinn, G. A., & Steven, J. (2011) · InTech eBooks · doi:10.5772/27511 · Cited by 5

Phenotypes associated with psychiatric disorders are sex-specific in a mutant mouse line.

Nakajima, M., Watanabe, T., Aoki, R., Shimizu, R., Okuyama, S., & Furukawa, Y. (2016) · Brain Research · doi:10.1016/j.brainres.2016.09.037 · Cited by 4

Detecting synaptic autoantibodies in psychoses: need for more sensitive methods

Masdeu, J. C. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000447 · Cited by 5

Time-Dependent Alterations in the Expression of NMDA Receptor Subunits along the Dorsoventral Hippocampal Axis in an Animal Model of Nascent Psychosis

Dubovyk, V., & Manahan‐Vaughan, D. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00017 · Cited by 5

Memantine ameliorates the impairment of social behaviors induced by a single social defeat stress as juveniles

Yoshida, M., Hasegawa, S., Taniguchi, M., Mouri, A., Suzuki, C., Yoshimi, A., Mamiya, T., Ozaki, N., & Noda, Y. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109208 · Cited by 5

In Silico and In Vitro Screening of Serine Racemase Agonist and In Vivo Efficacy on Alzheimer’s Disease Drosophila melanogaster

Lu, C., Chang, H., Hsu, L., Lee, M., Cheng, J., Wu, D., & Lin, W. (2023) · Pharmaceuticals · doi:10.3390/ph16020280 · Cited by 5

How and Why to Apply the Latest Technology*

Czarnik, A. W., & Mei, H. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00048-1 · Cited by 6

Estudos traducionais de neuropsiquiatria e esquizofrenia: modelos animais genéticos e de neurodesenvolvimento

Gottschalk, M. G., Sarnyai, Z., Guest, P. C., Harris, L. W., & Bahn, S. (2012) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832012005000007 · Cited by 5

NMDA synapses can bias competition between object representations and mediate attentional selection

Raffone, A., Murre, J. M. J., & Wolters, G. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03400022 · Cited by 6

Impact of Transgenic Technologies on Functional Genomics

Shashikant, C. S., & Ruddle, F. H. (2003) · Current Issues in Molecular Biology · doi:10.21775/cimb.005.075 · Cited by 5

3.2 Role of Dopamine Transporters in Neuronal Homeostasis

Caron, M. G., & Gainetdinov, R. R. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195373035.003.0007 · Cited by 5

Molecular Properties and Cell Biology of the NMDA Receptor

Wenthold, R. J., Al‐Hallaq, R. A., Swanwick, C. C., & Petralia, R. S. (2008) · Springer eBooks · doi:10.1007/978-0-387-77232-5_12 · Cited by 5

Altered higher brain function in PACAP-knockout mice

Shintani, N., Hashimoto, H., & Akemichi, B. A. B. A. (2004) · Folia Pharmacologica Japonica · doi:10.1254/fpj.123.274 · Cited by 5

Animal Models of Schizophrenia

Lipska, B. K., & Weinberger, D. R. (2003) · Wiley eBooks · doi:10.1002/9780470987353.ch21 · Cited by 6

Spermidine Treatment Improves GRIN2B Loss‐Of‐Function, A Primary Disorder of Glutamatergic Neurotransmission

Santos‐Gómez, A., Juliá‐Palacios, N., Rejano‐Bosch, A., Marí-Vico, R., Míguez‐Cabello, F., Masana, M., Soto, D., Olivella, M., García‐Cazorla, À., & Altafaj, X. (2025) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.70015 · Cited by 4

Integrated genetic and genomic approach in the Singapore translational and clinical research in psychosis study: an overview

Sim, K., Lee, J., Subramaniam, M., Liu, J., Keefe, R. S. E., Zhang, X. D., Lee, T.-S. W., & Chong, S. A. (2011) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2011.00272.x · Cited by 4

Effects of phencyclidine on schedule-controlled responding following neurotoxic lesions of the striatum

Carlson, K. M., & Wagner, G. C. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.08.043 · Cited by 4

Epinephrine potentiates antipsychotic, but not cataleptogenic effect of haloperidol in rats

Гмиро, В. Е., & Serdyuk, S. E. (2007) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-007-0197-5 · Cited by 4

Endocrinology of bone/brain crosstalk

Metozzi, A., Bonamassa, L., Brandi, G., & Brandi, M. L. (2015) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.979787 · Cited by 4

GLS1 Mutant Mice Display Moderate Alterations of Hippocampal Glutamatergic Neurotransmission Associated with Specific Adaptive Behavioral Changes

Dutar, P., Tolle, V., Kervern, M., Carcenac, C., Carola, V., Gross, C. T., Savasta, M., Darmon, M. C., & Masson, J. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.11.022 · Cited by 4

Schizophrenia

Frӧhlich, F. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801560-5.00025-2 · Cited by 4

The Organization and Integrative Function of the Post-Synaptic Proteome

Grant, S. G. N., Husi, H., Choudhary, J. S., Cumiskey, M. A., Blackstock, W. P., & Armstrong, J. D. (2003) · Springer eBooks · doi:10.1007/978-1-4615-0039-1_2 · Cited by 4

Peeling the onion: NMDA dysfunction as a unifying model in schizophrenia

Javitt, D. C. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x0333002x · Cited by 4

Glutamate and Schizophrenia and the N-Methyl-d-Aspartate Receptor Hypofunction Hypothesis

Bleich, S., & Kornhuber, J. (2005) · Humana Press eBooks · doi:10.1007/978-1-59259-852-6_7 · Cited by 4

Genetic Markers in Psychiatric Genetics

Bourgeron, T., & Giros, B. (2003) · Humana Press eBooks · doi:10.1385/1-59259-348-8:63 · Cited by 4

Schizophrenic cognition: Taken out of context?

Hemsley, D. R. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03310027 · Cited by 4

NMDAR-mediated transcriptional control of gene expression during the development of medial ganglionic eminence-derived interneuronsPreprint

Mahadevan, V., Mitra, A., Zhang, Y., Yuan, X. Q., Peltekian, A., Chittajallu, R., Esnault, C., Maric, D., Rhodes, C. T., Pelkey, K. A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.10.144295 · Cited by 4

β-hydroxybutyrate improves convulsions in mice carrying the GRIN1 Y647S/+ pathogenic variantPreprint

Sullivan, M. T., Tidball, P., Yan, Y., Intson, K., Chen, W., Xu, Y., Venkatesan, S., Horsfall, W., Georgiou, J., Finnie, P. S. B., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.21.608984 · Cited by 4

Memantine Exacerbates Trimethyltin‐Induced Neurodegeneration and Delays Cognitive Impairment Recovery

Onaka, Y., Yamaguchi, T., Yamasaki, T., Morishige, K., & Yoneyama, M. (2025) · Neuropsychopharmacology Reports · doi:10.1002/npr2.70014 · Cited by 3

Emerging Roles of GluN3B NMDA Receptor Subunit in the Central Nervous System

Huang, Y., Xie, J., Chen, J., Guo, S., Li, Y., & Liu, F. (2025) · Neuroscience Bulletin · doi:10.1007/s12264-025-01523-z · Cited by 3

Modeling Schizophrenia in Neuregulin 1 and ErbB4 Mutant Mice

Lu, Y., Yin, D., Xiong, W., & Mei, L. (2011) · Neuromethods · doi:10.1007/978-1-61779-157-4_12 · Cited by 3

Animal Models of Schizophrenia with a Focus on Models Targeting NMDA Receptors

Svojanovská, M., & Stuchlı́k, A. (2015) · Cognitive Remediation Journal · doi:10.5507/crj.2015.001 · Cited by 3

NU-1223, a Simplified Analog of Alstonine, with 5-HT2cR Agonist-Like Activity, Rescues Memory Deficit and Positive and Negative Symptoms in Subchronic Phencyclidine Mouse Model of Schizophrenia

Rajagopal, L., Mahjour, S., Huang, M., Ryan, C., Elzokaky, A., Csakai, A., Orr, M. J., Scheidt, K. A., & Meltzer, H. Y. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114614 · Cited by 3

Combination of Haloperidol With UNC9994, β-arrestin-Biased Analog of Aripiprazole, Ameliorates Schizophrenia-Related Phenotypes Induced by NMDAR Deficit in Mice

Lipina, T. V., Giang, H., Thacker, J. S., Wetsel, W. C., Caron, M. G., Beaulieu, J., Salahpour, A., & Ramsey, A. J. (2024) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyae060 · Cited by 3

Serine Racemase Knockout Mice: Neurotoxicity, Epilepsy, and Schizophrenia

Inoue, R., & Mori, H. (2016) · Springer eBooks · doi:10.1007/978-4-431-56077-7_8 · Cited by 3

Role of Glycine in Schizophrenia

Kretschmer, B. D. (2005) · Humana Press eBooks · doi:10.1007/978-1-59259-852-6_8 · Cited by 3

Establishment of L-3,4-Dihydroxyphenilalaninde-induced pharmacological dementia model mouse

Itokazu, N., Yamamoto, K., Ouchi, Y., & Cyong, J. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01823-7 · Cited by 3

Biochemical and genetic aspects of pathogenesis of schizophrenia

Камбарова, Д. К., & Golubev, A. G. (2011) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093011050021 · Cited by 3

Guarding against over-inclusive notions of “context”: Psycholinguistic and electrophysiological studies of specific context functions in schizophrenia

Titone, D. A., & Debruille, J. B. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03470027 · Cited by 3

d-Amino Acid Oxidase and d-Aspartate Oxidase

Kato, Y., Tran, D. H., Trinh, H. T. T., & Fukui, K. (2016) · Springer eBooks · doi:10.1007/978-4-431-56077-7_19 · Cited by 3

Overview of the NMDA Receptor

Mori, H. (2017) · Springer eBooks · doi:10.1007/978-3-319-49795-2_1 · Cited by 3

Cre-Activation in ErbB4-Positive Neurons of Floxed Grin1/NMDA Receptor Mice Is Not Associated With Major Behavioral Impairment

Mallien, A. S., Pfeiffer, N., Vogt, M. A., Chourbaji, S., Sprengel, R., Gass, P., & Inta, D. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.750106 · Cited by 3

A Historical Perspective on the Dopamine D3 Receptor

Sokoloff, P., & Foll, B. L. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_315 · Cited by 3

Cortical connectivity in high-frequency beta-rhythm in schizophrenics with positive and negative symptoms

Стрелец, В. Б. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03440028 · Cited by 3

Doctor of Philosophy (PhD)

Biss, M. (2015) · Cited by 3

The Neuroscientist comments

Wu, Q., & Maniatis, T. (2000) · The Neuroscientist · doi:10.1177/107385840000600104 · Cited by 3

TAAR1 modulates cortical glutamate NMDA receptor function

Espinoza, S. (2016) · Intrinsic Activity · doi:10.25006/ia.4.s2-a18.75 · Cited by 3

Brain region-specific changes in neurons and glia and dysregulation of dopamine signaling in Grin2a mutant micePreprint

Farsi, Z., Nicolella, A. A., Simmons, S., Aryal, S., Shepard, N., Brenner, K. S., Lin, S., Herzog, L. E., Shin, W., Gazestani, V., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.15.516665 · Cited by 2

Chronic social stress in early life can predispose mice to antisocial maltreating behavior

Jeon, D., Kim, S., Lee, S. K., & Chu, K. (2024) · encephalitis · doi:10.47936/encephalitis.2023.00199 · Cited by 2

MK-801-exposure induces increased translation efficiency and mRNA hyperacetylation of Grin2a in the mouse prefrontal cortex

Xue, L., Zhao, J., Liu, X., Zhao, T., Zhang, Y., & Ye, H. (2024) · Epigenetics · doi:10.1080/15592294.2024.2417158 · Cited by 2

Drug discovery strategy for TAK-418, a specific inhibitor of LSD1 enzyme activity, as a novel therapy for autism

Matsuda, S., Hattori, Y., & Kimura, H. (2024) · Advances in pharmacology · doi:10.1016/bs.apha.2024.10.017 · Cited by 2

Parsing the neuroanatomy of schizophrenia to enhance the translational validity of preclinical models - a multidisciplinary perspective

MORRIS, B. J. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111628 · Cited by 2

Meta-analyses of nine polymorphisms of six genes with the risk of schizophrenia

Xu, X., Wang, L., Liao, Q., Xu, L., Huang, Y., Zhang, F., Cheng, J. R., Ye, M., Gao, S., & Duan, S. (2014) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2014.52012 · Cited by 2

Activation of Group II Metabotropic Glutamate Receptors (mGluR2 and mGluR3) as a Novel Approach for Treatment of Schizophrenia

Sheffler, D. J., & Conn, P. J. (2010) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0346-0241-9_6 · Cited by 2

Cannabidiol, but Not Δ9-Tetrahydrocannabinol, Has Strain- and Genotype-Specific Effects in Models of Psychosis

Mielnik, C. A., Li, C. K., Ramsey, A. J., Salahpour, A., Burnham, W. M., & Ross, R. A. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0125 · Cited by 2

Encéphalites auto-immunes à anticorps antirécepteurs-NMDA, une cause fréquente d’encéphalite en réanimation

Lamarque, M. D., Psimaras, D., Ducray, F., Pélieu, I., Sonneville, R., Demeret, S., Bolgert, F., Dehais, C., Camdessanché, J., Antoine, J.-C. G., et al. (2011) · Réanimation · doi:10.1007/s13546-011-0275-6 · Cited by 2

The Effect of Subchronic Dosing of Ciproxifan and Clobenpropit on Dopamine and Histamine Levels in Rats

Mahmood, D., Pillai, K. K., Khanam, R., Jahan, K., Goswami, D., & Akhtar, M. (2015) · Journal of Experimental Neuroscience · doi:10.4137/jen.s27244 · Cited by 2

Phenomenology, context, and self-experience in schizophrenia

Sass, L. A., & Uhlhaas, P. J. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03430021 · Cited by 2

Insights from Proteomic Studies on Schizophrenia Preclinical Models: What Can We Learn for Drug Discovery?

Farrelly, L. A., Föcking, M., & Cotter, D. (2014) · Advances in biological psychiatry · doi:10.1159/000358028 · Cited by 2

[Stress and animal model of psychiatric disease].

Miyakawa, T., & Yamasaki, N. (2005) · Folia Pharmacologica Japonica · doi:10.1254/fpj.126.189 · Cited by 2

[Dysfunction of glutamatergic systems and potential animal models of schizophrenia].

Mouri, A., Noda, Y., Mizoguchi, H., & Nabeshima, T. (2006) · Folia Pharmacologica Japonica · doi:10.1254/fpj.127.4 · Cited by 2

Mouse Models of Schizophrenia

Desbonnet, L. (2015) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-800981-9.00016-x · Cited by 3

Behavioral Phenotypes of Genetic Mouse Models

Moran, P. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801829-3.00029-x · Cited by 2

Lack of barbering behavior in the phospholipase Cβ1 mutant mouse: a model animal for schizophrenia

Shin, H., Kim, D., & Koh, H.-Y. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511676109.008 · Cited by 2

Neuroimaging and the At-Risk Mental State

Lin, Y.-S., Fusar‐Poli, P., & Borgwardt, S. (2019) · Springer eBooks · doi:10.1007/978-3-319-97307-4_6 · Cited by 2

Reduced expression of synapsin II in a chronic phencyclidine preclinical rat model of schizophrenia

Thomson, S., Dyck, B. A., Daya, R. P., Ho, J., Bernardo, A. M., Tian, Y., & Mishra, R. K. (2018) · Synapse · doi:10.1002/syn.22084 · Cited by 2

Ionotropic Glutamate Receptors (and Their Role in Health and Disease)

Sprengel, R., & Eltokhi, A. (2022) · Springer eBooks · doi:10.1007/978-1-4614-6434-1_4-3 · Cited by 2

Imaging Monitoring Method of CaMKII Activity by Immunohistochemical Analysis in Schizophrenic Model Rats

Yabuki, Y., Nakagawasai, O., Tadano, T., & Fukunaga, K. (2013) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.12-00278-3 · Cited by 2

Phenomenology and Clinical Science of Schizophrenia

Ghose, S., & Tamminga, C. A. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn029 · Cited by 2

Pharmacogenomics and animal models of schizophrenia

Klink, R., Boksa, P., & Joober, R. (2003) · Drug Development Research · doi:10.1002/ddr.10288 · Cited by 2

Alteration of branch site consensus sequence and enhanced pre‐mRNA splicing of an NMDAR1 intron not associated with schizophrenia

Hammond, L. E., Castanotto, D., Rice, S. R., Nimgaonkar, V. L., Wirshing, D. A., Rossi, J. J., Heston, L. L., & Sobell, J. L. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10646 · Cited by 2

Neue Ergebnisse in der genetischen Forschung bei schizophrenen Psychosen

Rujescu, D. (2010) · Springer eBooks · doi:10.1007/978-3-211-92215-6_9 · Cited by 2

Restoring striatal WAVE-1 improves maze exploration performance of GluN1 knockdown micePreprint

Chen, Y., Milenkovic, M., Salahpour, A., Soderling, S. H., & Ramsey, A. J. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/341479 · Cited by 2

Mice Lacking PACAP: A Minireview Focussing on the Brain Function

Shintani, N. (2004) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.124.667 · Cited by 2

Animal Models for Schizophrenia: A Brief Overview

Furuta, M., & Kunugi, H. (2008) · Springer eBooks · doi:10.1007/978-0-387-79251-4_7 · Cited by 2

Beta-2 Oscillations

Roger, R. D., & Whittington, M. A. (2010) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195342796.003.0011 · Cited by 1

Ionotropic Glutamate Receptors (and Their Role in Health and Disease)

Sprengel, R., & Eltokhi, A. (2022) · Springer eBooks · doi:10.1007/978-3-030-88832-9_4 · Cited by 1

Preincubation with antipsychotic drugs protects against in vitro phencyclidine-mediated spontaneous neuronal network suppression

Faustmann, T. J., Theiss, S., Görtz, P., & Lange‐Asschenfeldt, C. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177810 · Cited by 1

Evaluation of preclinical antipsychotic models used to support first‐in‐human clinical trials

Nguyen, T. V. H., McKernan, D. P., & Kelly, J. P. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70284 · Cited by 1

Thalamofrontal synaptic weakening underlies short-term memory deficits from adolescent NMDAR hypofunction

Yu, J., Choi, I. S., Kim, G. H., Bahn, S.-K., Kim, J., Bae, S., Lee, T., Choi, J. H., Kwon, J. S., Kim, M., et al. (2026) · Science Advances · doi:10.1126/sciadv.aee2152 · Cited by 1

Linking brain to mind in normal behavior and schizophrenia

Grossberg, S. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03300020 · Cited by 1

A schizophrenic mouse?

Evans, K. L. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01619-6 · Cited by 1

Evaluation of latent learning in a water-finding test by using model animals

Mouri, A., Noda, Y., & Nabeshima, T. (2007) · Folia Pharmacologica Japonica · doi:10.1254/fpj.130.141 · Cited by 1

Schizophrenia

Abazyan, S., & Pletnikov, M. V. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.017 · Cited by 1

Anti-schizophrenic activities of histamine H3 receptor antagonists in rats treated with MK-801

Mahmood, D., & Akhtar, M. (2015) · Journal of Pre-Clinical and Clinical Research · doi:10.5604/18982395.1157569 · Cited by 1

Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia

Halene, T. B., Ehrlichman, R. S., Liang, Y., Christian, E. P., Jonak, G. J., Gur, T., Blendy, J. A., Dow, H. C., Brodkin, E. S., Schneider, F. W., et al. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00504.x · Cited by 162

NR1 knockdown mice as a representative model of the glutamate hypothesis of schizophrenia

Ramsey, A. J. (2009) · Progress in brain research · doi:10.1016/s0079-6123(09)17906-2 · Cited by 50

Mice lacking NR1 or NR2B protein die perinatally (For-

Mohn, A. R., Gainetdinov, R. R., Caron, M. G., & Koller, B. H. (2013)

The involvement of N-methyl-d-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia

Ju, P., & Cui, D. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv135 · Cited by 33

Reduced expression of the NMDA receptor-interacting protein SynGAP causes behavioral abnormalities that model symptoms of Schizophrenia

Guo, X., Hamilton, P. J., Reish, N. J., Sweatt, J. D., Miller, C. A., & Rumbaugh, G. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.223 · Cited by 120